FdaApplication
NDA 220295
Identifiers
- fda_app_no: NDA220295
Properties
| Property | Value |
|---|---|
| applicant_name | INTERCEPT PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2026-03-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LYNAVOY | LINERIXIBAT | 40MG | TABLET;ORAL |
1 product